The incidence and quantity of antiidiotypic antibody formation after OKT3 monoclonal therapy in heart-transplant recipients

Transplant Proc. 1990 Aug;22(4):1772-3.

Authors

C J Hesse¹, P Heyse, B J Stolk, A H Balk, N H Jutte, B Mochtar, W Weimar

Affiliation

¹ Department of Internal Medicine I, Erasmus University, Rotterdam, The Netherlands.

PMID: 2117805

No abstract available

Publication types

Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Anti-Idiotypic / analysis*
Antibodies, Monoclonal / immunology
Antibodies, Monoclonal / therapeutic use*
Azathioprine / therapeutic use
Combined Modality Therapy
Cyclosporins / therapeutic use
Enzyme-Linked Immunosorbent Assay
Fluorescent Antibody Technique
Heart Transplantation / immunology*
Humans
Immunosuppression Therapy*
Muromonab-CD3
Prednisone / therapeutic use
Transplantation, Homologous

Substances

Antibodies, Anti-Idiotypic
Antibodies, Monoclonal
Cyclosporins
Muromonab-CD3
Azathioprine
Prednisone